NDRA Snapshot
ENDRA Life Sciences Inc. develops technology for clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood for the treatment of nonalcoholic fatty liver disease, as well as temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
Market Capitalization$83,441,144
Price to Sales0.00
Earnings per Share$-1.6320
PE RatioNone
Most Recent Close$2.2200
52 Week High$3.05
52 Week Low$0.599
50-Day Moving Average$2.2712
200-Day Moving Average$1.1462
All data are from Alpha Vantage as of today. For more infomation on NDRA see Stock Dividend, Valuation, Price and Financial Data for Investors